Newsfeeds - Spark Newswire

2 minute read

Earnings

Osmotica Pharmaceuticals’s Return On Capital Employed Insights

Today, 1:34 PM

Osmotica Pharmaceuticals (NASDAQ:OSMT) brought in sales totaling $11.51 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 70.39%, resulting in a loss of $20.18 million.

OSMT

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 24, 2021

By Benzinga Insights

Today, 1:34 PM

Upgrades

ACHC

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 1:34 PM

Gainers MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.2 billion.

ADIL

5 minute read

66 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:34 PM

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.

ABUS

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 1:34 PM

ACRX

4 minute read

48 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 1:34 PM

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.

ANY

1 minute read

Osmotica Pharmaceuticals Q2 EPS $(0.28) Misses $(0.14) Estimate, Upneeq Revenue $11.5M

By Bill Haddad

Today, 1:34 PM

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.14) by 100 percent. This is a 27.27 percent decrease over losses of $(0.22) per

OSMT

8 minute read

Earnings Scheduled For August 16, 2021

By Benzinga Insights

Today, 1:34 PM

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

3 minute read

The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow

By Shanthi Rexaline

Today, 1:34 PM

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among those reporting during the week.

ABSI

5 minute read

The Daily Biotech Pulse: Lilly, Morphic’s Positive Data At ECCO, Humanigen’s COVID Treatment Gets Expedited Review In UK, TransCode IPO

By Shanthi Rexaline

Today, 1:34 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)

ABCL